Loading…

Pseudo-hyperthyroidism: Biotin interference in a case with renal failure

Biotin treatment causes false-low or false-high results in some immunoassays methods. This phenomenon is called as biotin interference. In the present article, a seven-month-old male, with renal failure and laboratory hyperthyroidism due to biotin interference is presented. High free T4 (fT4), free...

Full description

Saved in:
Bibliographic Details
Published in:Acta endocrinologica (Bucharest, Romania : 2005) Romania : 2005), 2021-07, Vol.17 (3), p.319-322
Main Authors: Demiral, M, Kiraz, Z K, Alataş, I O, Cetin, N, Kirel, B
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-f8def021d811d6c1e24004f2d77efe6e1d09592fb1fa7f71a49d9a24385dd1073
cites
container_end_page 322
container_issue 3
container_start_page 319
container_title Acta endocrinologica (Bucharest, Romania : 2005)
container_volume 17
creator Demiral, M
Kiraz, Z K
Alataş, I O
Cetin, N
Kirel, B
description Biotin treatment causes false-low or false-high results in some immunoassays methods. This phenomenon is called as biotin interference. In the present article, a seven-month-old male, with renal failure and laboratory hyperthyroidism due to biotin interference is presented. High free T4 (fT4), free T3 (fT3), anti-thyroid peroxidase antibody (anti-TPO), anti-thyroglobulin antibody (anti-TG) and low thyroid stimulating hormone (TSH) levels were detected in a seven-month-old male patient who has metabolic acidosis, renal failure, and suspected of metabolic disease. Anti-thyroid drug therapy was started. However, when he was re-evaluated due to the absence of euthyroidism with anti-thyroid therapy (methimazole 0.8 mg/kg /day), it was found that the patient had been given 20 mg/day biotin for acidosis for two months. Biotin interference was considered in hormone measurement. Thyroid function tests were found to be normal 12 days after discontinuation of biotin therapy. Immunoassay measurements which use biotin should be done 2-7days after the last dose of biotin in patients under biotin treatment, but this time may need be much longer in renal failure patients. During this period or if the biotin therapy cannot be stopped, alternative methods should be preferred for analysis.
doi_str_mv 10.4183/aeb.2021.319
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8919483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2644361227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-f8def021d811d6c1e24004f2d77efe6e1d09592fb1fa7f71a49d9a24385dd1073</originalsourceid><addsrcrecordid>eNpVkM9LwzAUx4Mobk5vnqVHD3bmJWmbehB0qBMGelDwFrLmxUa6diatsv_ezk3R0_v15ft9fAg5BjoWIPm5xvmYUQZjDvkOGYIUPKZp-rL73UNMc5kNyEEIb5QmkgLskwFPuGAilUMyfQzYmSYuV0v0bbnyjTMuLC6ia9e0ro5c3aK36LEusB8iHRU6YPTp2jLql7qKrHZV5_GQ7FldBTza1hF5vr15mkzj2cPd_eRqFhdcija20qDtvzUSwKQFIBOUCstMlqHFFMHQPMmZnYPVmc1Ai9zkmgkuE2OAZnxELje-y26-QFNg3XpdqaV3C-1XqtFO_b_UrlSvzYeSOeRC8t7gdGvgm_cOQ6sWLhRYVbrGpguKpULwFBhbZ51tpIVvQvBof2OAqjV81cNXa_iqh9_LT_6-9iv-oc2_AFR0gYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644361227</pqid></control><display><type>article</type><title>Pseudo-hyperthyroidism: Biotin interference in a case with renal failure</title><source>PubMed Central Free</source><creator>Demiral, M ; Kiraz, Z K ; Alataş, I O ; Cetin, N ; Kirel, B</creator><creatorcontrib>Demiral, M ; Kiraz, Z K ; Alataş, I O ; Cetin, N ; Kirel, B</creatorcontrib><description>Biotin treatment causes false-low or false-high results in some immunoassays methods. This phenomenon is called as biotin interference. In the present article, a seven-month-old male, with renal failure and laboratory hyperthyroidism due to biotin interference is presented. High free T4 (fT4), free T3 (fT3), anti-thyroid peroxidase antibody (anti-TPO), anti-thyroglobulin antibody (anti-TG) and low thyroid stimulating hormone (TSH) levels were detected in a seven-month-old male patient who has metabolic acidosis, renal failure, and suspected of metabolic disease. Anti-thyroid drug therapy was started. However, when he was re-evaluated due to the absence of euthyroidism with anti-thyroid therapy (methimazole 0.8 mg/kg /day), it was found that the patient had been given 20 mg/day biotin for acidosis for two months. Biotin interference was considered in hormone measurement. Thyroid function tests were found to be normal 12 days after discontinuation of biotin therapy. Immunoassay measurements which use biotin should be done 2-7days after the last dose of biotin in patients under biotin treatment, but this time may need be much longer in renal failure patients. During this period or if the biotin therapy cannot be stopped, alternative methods should be preferred for analysis.</description><identifier>ISSN: 1841-0987</identifier><identifier>EISSN: 1843-066X</identifier><identifier>DOI: 10.4183/aeb.2021.319</identifier><identifier>PMID: 35342468</identifier><language>eng</language><publisher>Romania: Carol Davila University Press</publisher><subject>General Endocrinology</subject><ispartof>Acta endocrinologica (Bucharest, Romania : 2005), 2021-07, Vol.17 (3), p.319-322</ispartof><rights>2021 Acta Endocrinologica (Buc).</rights><rights>2021 Acta Endocrinologica (Buc) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-f8def021d811d6c1e24004f2d77efe6e1d09592fb1fa7f71a49d9a24385dd1073</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919483/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919483/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35342468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Demiral, M</creatorcontrib><creatorcontrib>Kiraz, Z K</creatorcontrib><creatorcontrib>Alataş, I O</creatorcontrib><creatorcontrib>Cetin, N</creatorcontrib><creatorcontrib>Kirel, B</creatorcontrib><title>Pseudo-hyperthyroidism: Biotin interference in a case with renal failure</title><title>Acta endocrinologica (Bucharest, Romania : 2005)</title><addtitle>Acta Endocrinol (Buchar)</addtitle><description>Biotin treatment causes false-low or false-high results in some immunoassays methods. This phenomenon is called as biotin interference. In the present article, a seven-month-old male, with renal failure and laboratory hyperthyroidism due to biotin interference is presented. High free T4 (fT4), free T3 (fT3), anti-thyroid peroxidase antibody (anti-TPO), anti-thyroglobulin antibody (anti-TG) and low thyroid stimulating hormone (TSH) levels were detected in a seven-month-old male patient who has metabolic acidosis, renal failure, and suspected of metabolic disease. Anti-thyroid drug therapy was started. However, when he was re-evaluated due to the absence of euthyroidism with anti-thyroid therapy (methimazole 0.8 mg/kg /day), it was found that the patient had been given 20 mg/day biotin for acidosis for two months. Biotin interference was considered in hormone measurement. Thyroid function tests were found to be normal 12 days after discontinuation of biotin therapy. Immunoassay measurements which use biotin should be done 2-7days after the last dose of biotin in patients under biotin treatment, but this time may need be much longer in renal failure patients. During this period or if the biotin therapy cannot be stopped, alternative methods should be preferred for analysis.</description><subject>General Endocrinology</subject><issn>1841-0987</issn><issn>1843-066X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkM9LwzAUx4Mobk5vnqVHD3bmJWmbehB0qBMGelDwFrLmxUa6diatsv_ezk3R0_v15ft9fAg5BjoWIPm5xvmYUQZjDvkOGYIUPKZp-rL73UNMc5kNyEEIb5QmkgLskwFPuGAilUMyfQzYmSYuV0v0bbnyjTMuLC6ia9e0ro5c3aK36LEusB8iHRU6YPTp2jLql7qKrHZV5_GQ7FldBTza1hF5vr15mkzj2cPd_eRqFhdcija20qDtvzUSwKQFIBOUCstMlqHFFMHQPMmZnYPVmc1Ai9zkmgkuE2OAZnxELje-y26-QFNg3XpdqaV3C-1XqtFO_b_UrlSvzYeSOeRC8t7gdGvgm_cOQ6sWLhRYVbrGpguKpULwFBhbZ51tpIVvQvBof2OAqjV81cNXa_iqh9_LT_6-9iv-oc2_AFR0gYg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Demiral, M</creator><creator>Kiraz, Z K</creator><creator>Alataş, I O</creator><creator>Cetin, N</creator><creator>Kirel, B</creator><general>Carol Davila University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210701</creationdate><title>Pseudo-hyperthyroidism: Biotin interference in a case with renal failure</title><author>Demiral, M ; Kiraz, Z K ; Alataş, I O ; Cetin, N ; Kirel, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-f8def021d811d6c1e24004f2d77efe6e1d09592fb1fa7f71a49d9a24385dd1073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>General Endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Demiral, M</creatorcontrib><creatorcontrib>Kiraz, Z K</creatorcontrib><creatorcontrib>Alataş, I O</creatorcontrib><creatorcontrib>Cetin, N</creatorcontrib><creatorcontrib>Kirel, B</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demiral, M</au><au>Kiraz, Z K</au><au>Alataş, I O</au><au>Cetin, N</au><au>Kirel, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pseudo-hyperthyroidism: Biotin interference in a case with renal failure</atitle><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle><addtitle>Acta Endocrinol (Buchar)</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>17</volume><issue>3</issue><spage>319</spage><epage>322</epage><pages>319-322</pages><issn>1841-0987</issn><eissn>1843-066X</eissn><abstract>Biotin treatment causes false-low or false-high results in some immunoassays methods. This phenomenon is called as biotin interference. In the present article, a seven-month-old male, with renal failure and laboratory hyperthyroidism due to biotin interference is presented. High free T4 (fT4), free T3 (fT3), anti-thyroid peroxidase antibody (anti-TPO), anti-thyroglobulin antibody (anti-TG) and low thyroid stimulating hormone (TSH) levels were detected in a seven-month-old male patient who has metabolic acidosis, renal failure, and suspected of metabolic disease. Anti-thyroid drug therapy was started. However, when he was re-evaluated due to the absence of euthyroidism with anti-thyroid therapy (methimazole 0.8 mg/kg /day), it was found that the patient had been given 20 mg/day biotin for acidosis for two months. Biotin interference was considered in hormone measurement. Thyroid function tests were found to be normal 12 days after discontinuation of biotin therapy. Immunoassay measurements which use biotin should be done 2-7days after the last dose of biotin in patients under biotin treatment, but this time may need be much longer in renal failure patients. During this period or if the biotin therapy cannot be stopped, alternative methods should be preferred for analysis.</abstract><cop>Romania</cop><pub>Carol Davila University Press</pub><pmid>35342468</pmid><doi>10.4183/aeb.2021.319</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1841-0987
ispartof Acta endocrinologica (Bucharest, Romania : 2005), 2021-07, Vol.17 (3), p.319-322
issn 1841-0987
1843-066X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8919483
source PubMed Central Free
subjects General Endocrinology
title Pseudo-hyperthyroidism: Biotin interference in a case with renal failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A44%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pseudo-hyperthyroidism:%20Biotin%20interference%20in%20a%20case%20with%20renal%20failure&rft.jtitle=Acta%20endocrinologica%20(Bucharest,%20Romania%20:%202005)&rft.au=Demiral,%20M&rft.date=2021-07-01&rft.volume=17&rft.issue=3&rft.spage=319&rft.epage=322&rft.pages=319-322&rft.issn=1841-0987&rft.eissn=1843-066X&rft_id=info:doi/10.4183/aeb.2021.319&rft_dat=%3Cproquest_pubme%3E2644361227%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-f8def021d811d6c1e24004f2d77efe6e1d09592fb1fa7f71a49d9a24385dd1073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2644361227&rft_id=info:pmid/35342468&rfr_iscdi=true